Nano-enabled delivery of natural products and combinatorial chemotherapy for triple-negative breast cancers: mechanisms, synergy, and translational challenges
Among breast cancer subtypes, Triple-negative breast cancer (TNBC) is recognized for its aggressive behavior and is characterized by the absence of hormone receptors (estrogen and progesterone) and HER2 overexpression. This absence results in fewer treatment options and less favorable health outcomes. Conventional chem...